ERB Stock UPDATES Erba Diagnostics Inc (ERB) 3.56 09/17/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 17, 2014 at 5:40 AM

Erba Diagnostics Inc (ERB) 3.56 $ERB

Varian Medical Systems Joins Hands with Software Company - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 12:40PM CDT
Varian Medical Systems (VAR) will utilize all the modules available within the Infor Cloverleaf Integration and Information Exchange Suite.

Zimmer Up to Hold, Awaits EU Antitrust Nod on Biomet Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 5:40PM CDT
On Aug 13, 2014, Zacks Investment Research upgraded U.S. orthopedic major Zimmer Holdings, Inc. (ZMH) to a Zacks Rank #3 (Hold).

PARTNER 5-Year Data Up for Edwards Lifesciences' Sapien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 2:30PM CDT
Edwards Lifesciences (EW) disclosed positive five-year data from the PARTNER trial.

Varian Medical Systems Installs Proton Therapy at Scripps - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 2:10PM CDT
Varian Medical Systems (VAR) will display its ProBeam system at the meeting of the American Society for Radiation Oncology (ASTRO) at the end of this week

Intuitive Surgical Continues to Face Lower Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 12:20PM CDT
Intuitive Surgical (ISRG) faces the risk of lower capital spending by hospitals particularly during the current changes emanating from healthcare reform in the U.S. and austerity measures in Europe.

The Cooper Companies Up to Strong Buy on Higher Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 12:10PM CDT
Driven by strong fiscal 2014-third-quarter results, higher fiscal 2014 guidance and the recent acquisition of Sauflon Pharmaceuticals, The Cooper Companies Inc. (COO) has been witnessing a positive trend in earnings estimate revisions.

Thoratec Gains on Start of HeartMate III US Clinical Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 11, 5:10PM CDT
The primary endpoint of Thoratec Corp.'s (THOR) randomized U.S. trial, comparing HeartMate III with HeartMate II, is a life without the need of device replacement and the occurrence of a stroke.

Teleflex Vascular System Gets 510(k) for Restated Indication - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 12:50PM CDT
The restated indication for Teleflex Incorporated's (TFX) EZ-IO Vascular Access System allows distal femur insertion in pediatric patients.

Accuray Signs CyberKnife and TomoTherapy Systems Deal - Analyst Blog
Pritha Agrawal - Zacks Investment Research - Wed Sep 10, 12:40PM CDT
The partnership with Premie, Inc. is expected to significantly enhance the visibility of Accuray Incorporated's (ARAY) CyberKnife and TomoTherapy Systems.

ERBA Diagnostics (ERB) in Focus: Stock Up 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 8:39AM CDT
ERBA Diagnostics, Inc. (ERB)was a big mover last session, as its shares rose nearly 7% on the day.

Teleflex Reports Favorable ARROW PICC Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 5:05PM CDT
Results of the study highlight that Teleflex Incorporated's (TFX) ARROW PICC with Chlorag+ard Technology considerably reduces PICC-related bloodstream infections and treatment costs.

Is Hologic (HOLX) Worth a Buy post Solid Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 1:50PM CDT
Hologic (HOLX) conceivably stands as an industry leader in the field of women's health, offering a wide variety of products

Mindray Medical Down to Strong Sell on Weak Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 12:30PM CDT
For 2014, three estimates moved down in the past 30 days for Mindray Medical International Limited (MR), with no upward revision, sinking the Zacks Consensus Estimate by 7.7% to $1.81 per share.

LabCorp's Enlighten Health Introduces Genomics Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 2:10PM CDT
However, the news failed to stir up investor confidence as LabCorp's (LH) share prices dropped 0.1% to eventually close at $107.98 on Friday.

Masimo SET Pulse Oximetry Now Also in Yale-New Haven - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 12:30PM CDT
Masimo Corporation's (MASI) SET technology has been clinically proven in over 100 independent studies to be the most accurate pulse oximetry under the most challenging conditions of motion and low perfusion.

Cyberonics Down 3.6% despite Favorable ANTHEM-HF Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:30PM CDT
Based on the encouraging ANTHEM-HF study results, Cyberonics (CYBX) is now eagerly awaiting the commercial launch of its new VITARIA System for ART.

CVS Health Gains on Early Withdrawal of Tobacco Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:10PM CDT
Share price of leading healthcare services provider CVS Health Corporation (CVS) ??? inched up 0.7% since it announced the end of tobacco sales at all its CVS/pharmacy retail stores.

Fluidigm Corp. (FLDM) Worth Watching: Stock Up 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 8:39AM CDT
Fluidigm Corporation (FLDM) was a big mover last session, as its shares rose over 5% on the day.

Syneron Medical (ELOS) Shows Strength: Stock Rises 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 7:51AM CDT
Syneron Medical Ltd. (ELOS) was a big mover last session, as its shares rose over 5% on the day.

Masimo Up on Rainbow Sensor Clearance in Europe, Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 5:45PM CDT
Masimo Corporation's (MASI) Rainbow DCI-mini sensor is designed to help clinicians quickly and easily spot-check haemoglobin levels in infants and children, thus facilitating the identification of anaemia.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...